{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T22:24:11Z","timestamp":1771367051138,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Current Problems in Cardiology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.cpcardiol.2019.100506","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T08:29:22Z","timestamp":1575275362000},"page":"100506","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sarcoidosis-Associated Pulmonary Hypertension: An Updated Review and Discussion of the Clinical Conundrum"],"prefix":"10.1016","volume":"46","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6739-5946","authenticated-orcid":false,"given":"Adrian","family":"daSilva-deAbreu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stacy A.","family":"Mandras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cpcardiol.2019.100506_bib0001","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s12471-016-0847-1","article-title":"Pulmonary hypertension complicating pulmonary sarcoidosis","volume":"24","author":"Huitema","year":"2016","journal-title":"Neth Heart J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0002","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1136\/thx.2005.042838","article-title":"Pulmonary hypertension associated with sarcoidosis: mechanisms, haemodynamics and prognosis","volume":"61","author":"Nunes","year":"2006","journal-title":"Thorax"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0003","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1378\/chest.97.2.500","article-title":"Successful treatment of sarcoidosis-associated pulmonary hypertension with corticosteroids","volume":"97","author":"Rodman","year":"1990","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0004","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1183\/09031936.93.03040403","article-title":"Effects of corticosteroid treatment on pulmonary haemodynamics in patients with sarcoidosis","volume":"3","author":"Gluskowski","year":"1990","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0005","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/pgmj.58.679.282","article-title":"Reversible pulmonary hypertension in sarcoidosis","volume":"58","author":"Davies","year":"1982","journal-title":"Postgrad Med J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0006","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1097\/MCP.0000000000000075","article-title":"Advanced pulmonary sarcoidosis","volume":"20","author":"Valeyre","year":"2014","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0007","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1183\/09031936.00175511","article-title":"Management of end-stage sarcoidosis: pulmonary hypertension and lung transplantation","volume":"39","author":"Shlobin","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0008","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1378\/chest.06-2822","article-title":"Six-minute walk test and health status assessment in sarcoidosis","volume":"132","author":"Baughman","year":"2007","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0009","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1378\/chest.120.3.866","article-title":"Vasoresponsiveness of sarcoidosis-associated pulmonary hypertension","volume":"120","author":"Preston","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0010","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1001\/archinte.1985.00360110188037","article-title":"Sarcoidosis and reactive pulmonary hypertension","volume":"145","author":"Barst","year":"1985","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0011","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1378\/chest.130.5.1481","article-title":"Sarcoidosis-associated pulmonary hypertension: outcome with long-term epoprostenol treatment","volume":"130","author":"Fisher","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0012","first-page":"A5700","article-title":"Outcomes of patients with pulmonary hypertension associated with sarcoidosis treated with epoprostenol","volume":"197","author":"Hon","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0013","first-page":"110","article-title":"Inhaled iloprost for sarcoidosis associated pulmonary hypertension","volume":"26","author":"Baughman","year":"2009","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0014","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1378\/chest.13-1766","article-title":"Bosentan for sarcoidosis-associated pulmonary hypertension: a double-blind placebo controlled randomized trial","volume":"145","author":"Baughman","year":"2014","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0015","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1378\/chest.08-1881","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension. A two-center experience","volume":"135","author":"Barnett","year":"2009","journal-title":"Chest."},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0016","first-page":"139","article-title":"Ambrisentan For Sarcoidosis Associated Pulmonary Hypertension","volume":"28","author":"Judson","year":"2011","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0017","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.healun.2007.11.576","article-title":"Pulmonary hypertension in end-stage pulmonary sarcoidosis: therapeutic effect of sildenafil?","volume":"27","author":"Milman","year":"2008","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0018","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1086\/688775","article-title":"Tadalafil therapy for sarcoidosis-associated pulmonary hypertension","volume":"6","author":"Ford","year":"2016","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0019","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1378\/chest.14-2546","article-title":"Prostacyclin and oral vasodilator therapy in sarcoidosis-associated pulmonary hypertension: a retrospective case series","volume":"148","author":"Bonham","year":"2015","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0020","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.amjcard.2012.09.031","article-title":"Clinical characteristics, haemodynamics and treatment of pulmonary hypertension in sarcoidosis in a single centre, and meta-analysis of the published data","volume":"111","author":"Dobarro","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0021","first-page":"A5889","article-title":"Bosentan for the treatment of sarcoidosis-associated pulmonary hypertension","volume":"183","author":"Palmero","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0022","doi-asserted-by":"crossref","first-page":"4061","DOI":"10.1038\/s41598-019-40030-w","article-title":"Clinical features and outcomes of patients with sarcoidosis-associated pulmonary hypertension","volume":"9","author":"Parikh","year":"2019","journal-title":"Sci Rep"},{"issue":"Suppl.56","key":"10.1016\/j.cpcardiol.2019.100506_bib0023","first-page":"942","article-title":"Long-term bosentan therapy improves exercise capacity and hemodynamics in sarcoidosis-associated pulmonary hypertension","volume":"40","author":"Qua","year":"2012","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0024","first-page":"A4082","article-title":"Pulmonary vasodilator therapy showed clinical improvement in patients with sarcoidosis associated pulmonary hypertension","volume":"189","author":"Bhandari","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0025","first-page":"A1509","article-title":"Outcomes of directed pah therapy in sarcoidosis","volume":"197","author":"Albujoq","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0026","first-page":"82","article-title":"Treatment of sarcoidosis-associated pulmonary hypertension: a single centre retrospective experience using targeted therapies","volume":"31","author":"Keir","year":"2014","journal-title":"Sarcoidosis Vasculitis and Diffuse Lung Diseases"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0027","doi-asserted-by":"crossref","first-page":"1700465","DOI":"10.1183\/13993003.00465-2017","article-title":"Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension","volume":"50","author":"Boucly","year":"2017","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0028","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.hlc.2007.12.006","article-title":"Improvement after angioplasty and stenting of pulmonary arteries due to sarcoid mediastinal fibrosis","volume":"18","author":"Hamilton-Craig","year":"2009","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0029","doi-asserted-by":"crossref","DOI":"10.1177\/2045894018768289","article-title":"A case of sarcoidosis-associated pulmonary hypertension masquerading as chronic thromboembolic pulmonary hypertension","volume":"8","author":"Bazmpani","year":"2018","journal-title":"Pulm Circ"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0030","doi-asserted-by":"crossref","first-page":"1701502","DOI":"10.1183\/13993003.01502-2017","article-title":"Balloon pulmonary angioplasty in sarcoid-related pulmonary hypertension","volume":"51","author":"Tramper","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0031","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s12890-018-0695-4","article-title":"Balloon pulmonary angioplasty - efficient therapy of chronic thromboembolic pulmonary hypertension in the patient with advanced sarcoidosis - a case report","volume":"18","author":"Labyk","year":"2018","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0032","first-page":"281","article-title":"Pulmonary stenting for the treatment of sarcoid induced pulmonary vascular stenosis","volume":"33","author":"Condado","year":"2016","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0033","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/crj.12435","article-title":"Interventional therapy in sarcoidosis-associated pulmonary arterial stenosis and pulmonary hypertension","volume":"11","author":"Liu","year":"2017","journal-title":"Clin Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0034","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1747-0803.2010.00387.x","article-title":"Results of intravascular stent placement for fibrosing mediastinitis","volume":"5","author":"Ferguson","year":"2010","journal-title":"Congenit Heart Dis"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0035","first-page":"256","article-title":"Sarcoidosis with major airway, vascular and nerve compromise","volume":"20","author":"Sekiguchi","year":"2013","journal-title":"Can Respir J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0036","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1378\/chest.120.3.873","article-title":"Characteristics and outcomes of patients with sarcoidosis listed for lung transplantation","volume":"120","author":"Arcasoy","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0037","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1378\/chest.122.1.233","article-title":"Outcomes for patients with sarcoidosis awaiting lung transplantation","volume":"122","author":"Shorr","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0038","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.healun.2006.03.011","article-title":"International guidelines for the selection of lung transplant candidates: 2006 update\u2013a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation","volume":"25","author":"Orens","year":"2006","journal-title":"J Heart Lung Transp"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0039","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healun.2014.06.014","article-title":"A consensus document for the selection of lung transplant candidates: 2014\u2013an update from the Pulmonary Transplantation Council of the International Society for Heart and Lung Transplantation","volume":"34","author":"Weill","year":"2015","journal-title":"J Heart Lung Transp"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0040","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.healun.2014.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: thirty-first adult lung and heart-lung transplant report\u20132014; focus theme: retransplantation","volume":"33","author":"Yusen","year":"2014","journal-title":"J Heart Lung Transp"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0041","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/01.CIR.58.6.1204","article-title":"Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis","volume":"58","author":"Silverman","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0042","first-page":"26","article-title":"Racial difference in cardiac sarcoidosis incidence observed at autopsy","volume":"11","author":"Iwai","year":"1994","journal-title":"Sarcoidosis"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0043","first-page":"167","article-title":"Causes of death in patients with sarcoidosis. A morphologic study of 38 autopsies with clinicopathologic correlations","volume":"119","author":"Perry","year":"1995","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0044","first-page":"377","article-title":"Pathological studies on sarcoidosis autopsy. II. Early change, mode of progression and death pattern","volume":"43","author":"Iwai","year":"1993","journal-title":"Acta Pathol Jpn"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0045","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1161\/CIRCULATIONAHA.114.011522","article-title":"Cardiac sarcoidosis: epidemiology, characteristics, and outcome over 25 years in a nationwide study","volume":"131","author":"Kandolin","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0046","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1253\/circj.CJ-17-0701","article-title":"Trends in hospitalizations for cardiac sarcoidosis in the United States, 2005-2011","volume":"81","author":"Guo","year":"2017","journal-title":"Circ J"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0047","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1378\/chest.09-2002","article-title":"Survival in sarcoidosis-associated pulmonary hypertension: the importance of hemodynamic evaluation","volume":"138","author":"Baughman","year":"2010","journal-title":"Chest"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0048","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00408-012-9442-4","article-title":"Elevated pulmonary arterial systolic pressure in patients with sarcoidosis: prevalence and risk factors","volume":"191","author":"Rapti","year":"2013","journal-title":"Lung"},{"key":"10.1016\/j.cpcardiol.2019.100506_bib0049","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/MCP.0b013e328363f4a3","article-title":"Sarcoidosis-associated pulmonary hypertension","volume":"19","author":"Cordova","year":"2013","journal-title":"Curr Opin Pulm Med"}],"container-title":["Current Problems in Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280619301793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0146280619301793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T02:00:06Z","timestamp":1758938406000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0146280619301793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S0146280619301793"],"URL":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2019.100506","relation":{},"ISSN":["0146-2806"],"issn-type":[{"value":"0146-2806","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sarcoidosis-Associated Pulmonary Hypertension: An Updated Review and Discussion of the Clinical Conundrum","name":"articletitle","label":"Article Title"},{"value":"Current Problems in Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cpcardiol.2019.100506","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}],"article-number":"100506"}}